Why BioMar Group stock moves
BioMar Group fell with the market.
Written after the close on ·
Why today
15,968 news analyzed todayBioMar Group fell with the market.
Over the last five trading days, BioMar Group fell very sharply while OMX Copenhagen 25 rose clearly, so it moved against the market.
Last session, the shares moved in line with OMX Copenhagen 25, which also fell clearly.
Investors had already digested the Q3 report, published earlier this week, which beat expectations but lowered the volume outlook.
The weaker run likely reflects doubts that record profit will last, since management called it temporary.
Today's move of −0.50% was 0.6 times a normal day's 0.8%. OMX Copenhagen 25 moved −0.64% on the same day.
BioMar Group −0.50%OMX Copenhagen 25 −0.64%In step with the market
What analysts expect, and how often they have been right
Analysts’ estimates for BioMar Group.
BioMar Group earned more than expected in 1 out of 2 reports.
The share moved in the same direction as the earnings surprise in 0 out of 2 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 120.40 DKK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedDKK
Next reported quarter: expected earnings per share of 3.47 DKK. For the current fiscal year, expected earnings per share changed from 8.22 DKK three months ago to 9.46 DKK now. 2026 estimate: 9.46 DKK. 2027 estimate: 10.16 DKK.
What the key figures say about BioMar Group
The figures connect what BioMar Group earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2023–2025: 4.59 DKK–7.10 DKK. Peers: Austevoll Seafood 3.70 NOK, Mowi 15.30 NOK, Grieg Seafood -1.90 NOK. 2026 estimate: 9.46 DKK (9.34 DKK–9.59 DKK). 2027 estimate: 10.16 DKK (9.99 DKK–10.60 DKK).
What the company sold during the year.
2023–2025: 16.5 bn DKK–17.9 bn DKK. Peers: Austevoll Seafood 37.9 bn NOK, Mowi 6.5 bn EUR, Grieg Seafood 3.6 bn NOK. 2026 estimate: 18.1 bn DKK (17.7 bn DKK–18.4 bn DKK). 2027 estimate: 19.2 bn DKK (18.4 bn DKK–20.1 bn DKK).
The percentage of revenue left after the costs of running the business.
2023–2025: 5.0%–6.9%. Peers: Austevoll Seafood 6.8%, Mowi 15.0%, Grieg Seafood 6.2%.
Profit as a percentage of shareholders’ money in the company.
2023–2025: 17.1%–22.3%. Peers: Austevoll Seafood 4.4%, Mowi 16.9%, Grieg Seafood 9.3%.
Net debt divided by operating earnings before depreciation and amortisation.
2023–2025: 2.13–3.74. Peers: Austevoll Seafood 2.86, Mowi 2.83, Grieg Seafood 11.05.
More key figures
Cash left after investments, divided by the number of shares.
2023–2025: 4.31 DKK–13.61 DKK. Peers: Austevoll Seafood 18.13 NOK, Mowi 0.70 EUR, Grieg Seafood -2.93 NOK.
The percentage of assets financed by shareholders’ equity.
2023–2025: 24.2%–28.8%.
Earnings report
−3.31% Why? +3.44%
10,000 DKK in BioMar Group bought on May 28, 2026 is worth 10,700 DKK today, with dividends reinvested.
The same amount in OMX Copenhagen with dividends would have become 10,900 DKK.
What would 10,000 DKK in BioMar Group be worth today? →
What would 10,000 DKK in BioMar Group be worth today?
10,700 DKK
with dividends reinvested, bought on May 28, 2026. The same amount in OMX Copenhagen with dividends would have become 10,900 DKK.
The five biggest days of the journey
· +6.8% · the whole market rose 0.9% the same day
· −5.3% · the whole market rose 0.6% the same day
· +4.6% · the whole market rose 0.8% the same day
· +3.8% · the whole market fell 0.1% the same day
· +3.5% · the whole market fell 1.0% the same day
Earlier days
−7.24% market +1.75% BioMar Group fell very sharply over the week while the Copenhagen market index rose clearly, so it moved against the market. Read →
BioMar Group fell very sharply over the week while the Copenhagen market index rose clearly, so it moved against the market.
The main driver was its Q3 2026 report on 2 November, which showed record volumes and earnings (EBIT, operating profit) and raised full-year revenue and EBIT guidance, its forecast.
Investors likely focused on the company warning that Q4 volumes would be softer and that the recent profit level may not last.
The company will host a results call on 3 November at 10:00 CET, the next event to watch.
−0.49% market +1.82% BioMar Group fell slightly while the market rose. Read →
BioMar Group fell slightly while the market rose.
No company news explains the move.
Over the last five trading days the shares fell sharply, while OMX Copenhagen 25 rose sharply.
Trading volume was about four times normal, so heavy selling is plausible.
Shares in this kind of consumer-defensive company often move with feed-cost expectations and earnings outlooks.
−2.87% market +0.22% BioMar Group fell sharply. Read →
BioMar Group fell sharply.
BioMar Group fell, while OMX Copenhagen 25 rose slightly, so it moved against the market.
Trading volume was about four times a normal session.
Its record Q3 results beat expectations and it raised its 2026 revenue and EBIT guidance, but lowered its volume guidance.
Traders likely reacted to the weaker volume outlook for the last quarter.
−3.31% market +0.59% BioMar Group fell after raising its 2026 guidance. Read →
BioMar Group fell after raising its 2026 guidance.
The company reported record third-quarter earnings and raised its full-year revenue and profit outlook, but cut its volume forecast.
While the company's guidance was lifted, the market sold the shares heavily, with trading about four times its usual level.
Over the same days the OMX Copenhagen 25 index rose slightly, so BioMar moved against the market.
Investors likely focused on the lower volume outlook and the warning that the strong profit is partly temporary, driven by high raw material prices and currency gains.
+0.00% market +0.07% BioMar Group was roughly unchanged. Read →
BioMar Group was roughly unchanged.
The session size was within its usual daily range, so it was an ordinary day for BioMar Group.
Over the last five trading days it moved less than OMX Copenhagen 25, which rose very sharply.
No company news from the last session explains the move.
Recent news included DNB Carnegie raising its price target, the fair share price it sees, to DKK 160, and Morgan Stanley raising its target to DKK 131.
−0.15% market +4.94% BioMar Group was roughly unchanged over the week's trading days, while the broader Copenhagen market rose very sharply, so it lagged. Read →
BioMar Group was roughly unchanged over the week's trading days, while the broader Copenhagen market rose very sharply, so it lagged.
Analysts were supportive: DNB Carnegie raised its price target, the share price it sees as fair, to DKK 160 and kept its buy rating, and Morgan Stanley raised its target to DKK 131 on Tuesday 27 October.
Trading volume was around its usual level.
Whether the sharp market gain or these target changes would move the shares further is not clear from the news.
+1.72% market +0.09% BioMar Group rose, with company news behind it. Read →
BioMar Group rose, with company news behind it.
DNB Carnegie raised its price target, the share price it sees as fair, to DKK 160 and kept its buy rating.
The market was roughly flat that day, so the move was BioMar's own.
Over the last five trading days, BioMar was roughly unchanged while OMX Copenhagen 25 rose sharply, so it lagged the market.
Earlier, Morgan Stanley raised its target to DKK 131 and BioMar launched a new feed product, BioRetain.
−0.99% market +0.57% BioMar Group fell clearly, moving against the market. Read →
BioMar Group fell clearly, moving against the market.
Morgan Stanley raised its price target, the share price it sees as fair, to DKK131, but that does not explain a fall.
Over the last five trading days the shares were roughly unchanged, while OMX Copenhagen 25 rose sharply, so BioMar lagged.
Trading volume was around its usual level, so no unusual activity stands out.
+0.77% market +1.34% BioMar Group rose slightly, without company news. Read →
BioMar Group rose slightly, without company news.
The stock rose less than OMX Copenhagen 25, which rose sharply over the same day.
No company news from the last session explains the move.
Over the last five trading days, the stock also rose slightly, while the market rose sharply.
The earlier news was a launch of a new fish feed product, BioRetain, announced the week before; that is background, not a cause of the session's move.
−0.15% market −0.63% BioMar Group had no company news, and the shares barely moved. Read →
BioMar Group had no company news, and the shares barely moved.
Over the last five trading days, the shares rose clearly while the wider Copenhagen market edged up, so the stock outperformed.
Trading was well below its usual level, which points to a quiet session.
The rise likely reflects the new feed product launch and farm trial results announced earlier this week, though this is not confirmed.
Watch the market's direction, since the shares can follow it on quiet days.
+3.17% market +0.86% BioMar Group rose clearly over the last five trading days, more than the wider Copenhagen market, which rose only slightly. Read →
BioMar Group rose clearly over the last five trading days, more than the wider Copenhagen market, which rose only slightly.
The main news was the launch of BioRetain, a new fish feed designed to keep nutrients in the feed so less is lost to the water, announced early in the week.
This likely supported the share price, since a new product can point to future sales growth.
Trading was quiet, so the move may have been driven by a small number of buyers.
+0.62% market +0.44% BioMar Group rose slightly, in line with the market. Read →
BioMar Group rose slightly, in line with the market.
No company news explains the move.
Over the last five trading days the shares rose sharply, well ahead of OMX Copenhagen 25, which rose slightly.
Trading was about twice a normal day, so interest was heavier than usual.
+2.30% market −0.85% BioMar Group rose sharply on the trading day while the market fell clearly. Read →
BioMar Group rose sharply on the trading day while the market fell clearly.
No company news explains the move.
Over the last five trading days, BioMar Group rose clearly, a bit more than the market.
The most likely reason is that investors kept buying after a supportive analyst update, Danske Bank's raised price target, which is the share price it sees as fair.
Its product news on nutrient retention in fish feed likely added to the interest.
Learn more · Why do stocks go up and down?